Medicines Distribution Consents and Revocations




NEW ZEALAND GAZETTE, No. 140

14 OCTOBER 2010


Product:

Roxanne 30/150
Active Ingredients:
Ethinylestradiol 30µg
Levonorgestrel 150µg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Pharbil Waltrop GmbH, Waltrop, Germany


Product:

Roxanne ED 20/100
Active Ingredients:
Ethinylestradiol 20µg
Levonorgestrel 100µg
Dosage Form:
Film coated tablet
Tablet
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Pharbil Waltrop GmbH, Waltrop, Germany


Product:

Roxanne ED 30/150
Active Ingredients:
Ethinylestradiol 30µg
Levonorgestrel 150µg
Dosage Form:
Film coated tablet
Tablet
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Pharbil Waltrop GmbH, Waltrop, Germany

Dated this 6th day of October 2010.

STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7897


Revocation of Consent to the Distribution of Medicines

Pursuant to section 35(1)(a) of the Medicines Act 1981, the Minister of Health hereby revokes consent to the distribution in New Zealand of the following medicines:

Product:

Meridia
Active Ingredient:
Sibutramine hydrochloride monohydrate 10mg
Dosage Form:
Capsule
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited


Product:

Meridia
Active Ingredient:
Sibutramine hydrochloride monohydrate 15mg
Dosage Form:
Capsule
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited


Product:

Reductil
Active Ingredient:
Sibutramine hydrochloride monohydrate 10mg
Dosage Form:
Powder filled capsule
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited


Product:

Reductil
Active Ingredient:
Sibutramine hydrochloride monohydrate 15mg
Dosage Form:
Powder filled capsule
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited


Product:

Reduxade
Active Ingredient:
Sibutramine hydrochloride monohydrate 10mg
Dosage Form:
Capsule
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited


Product:

Reduxade
Active Ingredient:
Sibutramine hydrochloride monohydrate 15mg
Dosage Form:
Capsule
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited

Dated this 11th day of October 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 20 December 2001 and the Director-General of Health on 18 January 2002).

go8014



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 140





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines under Medicines Act 1981 (continued from previous page)

🏥 Health & Social Welfare
6 October 2010
Medicines, Distribution, Roxanne 30/150, Roxanne ED 20/100, Roxanne ED 30/150
  • STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health

🏥 Revocation of Consent to the Distribution of Medicines

🏥 Health & Social Welfare
11 October 2010
Medicines, Revocation, Meridia, Reductil, Reduxade
  • JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health